<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Orthopedics

Comprehensive coverage you can count on.

 

Request a Demo

 

12 of the top 15 orthopedic companies depend on SmartTRAK!

We provide up-to-date intel on industry trends, news, financial data and competitor developments. Our team of analysts are experts in their field - all with previous industry experience. We have our finger on the pulse to bring you the most relevant and accurate data, analysis and intelligence so that you can make better, more informed strategic business decisions.

9 Analysts

8 Modules

697 Companies

5,331 Products

Direct Access

to our analysts when you need it.

Daily Updates

on the latest news, earnings calls, studies, patent filings, new products and more!

Analysis and Insights

featuring quarterly Market Recaps, Interviews, Conferences and more!

Q122 ORTHOBIO MARKET RECAP: Virtually all orthopedic/spine companies experienced the same pattern with elective procedures during the quarter. In general, elective procedure case counts were pressured in January through the beginning of February as a surge in COVID-19 cases impacted patients and contributed to staffing shortages at healthcare facilities.
james Petricek 400X400px
James Petricek
SmartTRAK GM, OrthoBiologics & Regen Med
Q122 EXTREMITIES MARKET RECAP: While growth drivers varied for specific companies in Q122, the return of elective procedure volumes helped drive double-digit growth for several market players.
Lisa Mahan
Lisa Mahan
SmartTRAK Senior Analyst, Total Joints & Extremities
Q122 US JOINT FLUID MARKET RECAP: Procedure volume recovery continues to be a trend on everyone’s radar from industry execs to healthcare providers. The Knee Replacement Market in the US seemed to experience a much stronger recovery than Hips based on YoY growth rates of +12.8% vs +5.7%, respectively, according to SmartTRAK Financial Dashboard.
Freddy Buntoum
Frederique "Freddy" Buntoum
SmartTRAK Senior Analyst, Orthobiologics & Regen Med
Q122 TRAUMA MARKET RECAP: Despite an overall healthy first quarter for the Trauma Market, players reported mixed results. Top players DePuy Synthes and Stryker experienced healthy returns.
Natasha_DSC_7156c 200x200
Natasha Weeks
SmartTRAK Senior Analyst, Trauma & Extremities Fixation
Q122 SOFT TISSUE FIXATION MARKET RECAP: With 2021 being a year of ups and downs due to the COVID pandemic, staffing shortages and supply chain issues, the start of 2022 looked to be no different.
Andy Knapnik-1
Andy Knapnik
SmartTRAK Senior Analyst, Soft Tissue & Arthroscopic Technologies
Q421/FY21 Spine Market Recap: The US Spine Hardware market saw Q421 growth limited, showing only +1.6% versus Q420, which is relatively flat compared to the same period from the prior year, and slightly improved from the declines seen in Q321.
Courtney Sheedy V2 (1) (Small)
Courtney Sheedy
SmartTRAK GM, Spine
Q421/FY21 ORTHO COMPUTER ASSISTED SURGERY RECAP: The Q421 WW CAS Ortho Market was up +31.6% YoY, while the FY21 WW CAS Ortho segment grew +34.9% YoY, according to SmartTRAK Financial Dashboard.
Elise Wolf
Elise Wolf
SmartTRAK GM, SmartTRAK Computer Assisted Surgery
Q122 Total Joints MARKET RECAP: Q122 US JOINT FLUID MARKET RECAP: Procedure volume recovery continues to be a trend on everyone’s radar from industry execs to healthcare providers. The Knee Replacement Market in the US seemed to experience a much stronger recovery than Hips, according to SmartTRAK Financial Dashboard.
Lisa Mahan
Lisa Mahan
Senior Analyst, Total Joints & Extremities
 

Orthopedics Modules

MODULE DETAILS

Extremities - US

Joint arthroplasty implants for shoulder, elbow, wrist, hand, ankle and foot; and internal and external fixation devices – excluding soft tissue fixation.

  • Upper Extremities – Clavicle through Finger
  • Foot & Ankle – Distal Tibia through Toe
  • Pediatric Extremities

OrthoBio - US

Biological or bio-inductive products used in orthopedic/spine/sports medicine applications – excluding amniotic derived products or cell processing.

  • Bone Replacement
  • Cartilage Replacement
  • Soft Tissue Replacement
    • Soft Tissue Augmentation
    • Knee Ligament Replacement Grafts
  • Meniscus Replacement
  • Joint Fluid Replacement

Spine - US

Spine hardware excluding biologics.

  • Spinal Fusion
    • Cervical Fusion
    • MIS Spinal Procedures
    • Thoracolumbar Fusion
    • Thoracolumbar Interbody
  • Disc Replacement
  • Dynamic Devices
  • Vertebral Compression Fracture (VCF)
  • Pediatric Spine 

Enabling Technologies - US

Surgical planning systems, navigation systems, robotics, radiation reduction technologies, augmented reality and artificial intelligence.

  • Spine Computer Assisted Surgery
  • Ortho Computer Assisted Surgery
  • Arthroscopic Technologies

Total Joints - US/WW

Hardware for total and partial joint arthroplasty.

  • Hip Replacement
  • Knee Replacement

Trauma - US

Hardware for trauma surgery excluding Upper Extremity and Foot & Ankle (which are covered under Extremities).

  • Plates & Screws
  • IM Nailing
  • External Fixation
  • Cannulated Screws
  • Trauma Other (Dynamic hip screws, cables)
  • Pediatric Trauma

Soft Tissue Fixation - US

Soft tissue fixation implants.

  • Extremity Soft Tissue Fixation
  • Hip Soft Tissue Fixation
  • Knee Soft Tissue Fixation
  • Shoulder Soft Tissue Fixation
  • Meniscus Repair
Region
  • EU Extremities -  Separate country Segments for: France, Germany, Italy, Spain and UK
  • EU Trauma - Separate country Segments for: France, Germany, Italy, Spain and UK

 

 

Analysis

SmartTRAK Analysis features curated content by our team of industry experts bringing the most relevant information and insight directly to you. Learn about the latest news, emerging technologies or start-ups to watch, conference happenings and more via articles, videos, and interviews we do. Our analysts keep you up-to-date on the latest market trends and competitive developments in our daily updates, quarterly market recaps and market overviews.

 

Orthopedics Markets

SmartTRAK gives you the most comprehensive coverage of major segments (both hardware and orthobiologics) of the Orthopedic industry. SmartTRAK Market Overviews provide a complete and up-to-date snapshot of what’s driving a market, what’s limiting growth and what new technologies are coming on the scene. From procedure volumes and 5-year forecasts to competitive shares, SmartTRAK Market Overviews contain the latest data and insights on Incidence & prevalence, new treatments and technologies, regulatory and reimbursement.

Download Modules & Segments PDF

 

Company Profiles

SmartTRAK profiles all of the public, private and not-for-profit players participating in a market segment. Succinct and up-to-date, each company profile is consistently formatted so you can make an apples-to-apples comparison of revenues, financings, product portfolios, acquisitions and strategic partnerships. Perfect for competitive analysis or M&A research.

 

Product Profiles

Product Profiles are robust and give an in-depth look into the most current information on a particular product. Each product profile includes a description of the technology, summary of clinical studies, regulatory approvals, sales and more —all with links to the original source.  Product profiles provide all of the information you need to size up a competitive product or learn about a new one.

 

Product Explorer Tool

Product Explorer Tool enables you to quickly drill down on the orthopedic market by segment, indication, regulatory status and more giving you an up-to-date view of the global competitive landscape in seconds.

 

Financial Dashboard Tool

Quickly size a market, gauge market share, compare year-over-year growth and spot trends. Users can sort data by market, segment, sub-segment, on quarterly or annual basis and can easily get the financial data they need.

 

Gap Analysis Tool

Quickly visualize your or your competitor’s product portfolio in seconds! Users can quickly see gaps in their own offering and identify potential candidates for acquisition targets that could potentially strengthen their own portfolio.